FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
MedicalXpress
|
六月 18, 2026
U.S. health advisers are debating a new kind of flu vaccine Thursday, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗